Semler Scientific Unveils Plan to Buy 105,000 BTC by 2027 in Bold Bitcoin Pivot

Semler Scientific’s Bold Bitcoin Acquisition Roadmap

Semler Scientific, a California-based Nasdaq-listed medical technology company (SMLR), has solidified its commitment to Bitcoin as its primary treasury reserve asset, unveiling an ambitious three-year acquisition plan.

• 2025: Semler Scientific aims to hold 10,000 Bitcoins by year-end.

• 2026: The company targets an increase to 42,000 Bitcoins by year-end.

• 2027: Semler Scientific plans to reach 105,000 Bitcoins by year-end, representing approximately 0.5% of Bitcoin’s total 21 million supply.

As of June 4, 2025, Semler already owns 4,449 Bitcoins, valued at $462 million.

The company plans to fund this aggressive expansion through a mix of equity and debt financing, alongside operational cash flows. This strategy mirrors the approach of other firms that have embraced Bitcoin as a hedge against inflation and a high-yield asset.

Since adopting the “Bitcoin Standard” in May 2024, Semler’s Bitcoin holdings have delivered a remarkable 287% return, generating $177 million in unrealized gains as of June 3, 2025, with a year-to-date return of 26.7% and a first-quarter 2025 return of 22.2%.

Joe Burnett to Lead Bitcoin Strategy

On June 19, 2025, Semler Scientific appointed Joe Burnett as its Director of Bitcoin Strategy to spearhead this transformative initiative.

Burnett, a seasoned Bitcoin expert with over seven years of experience in market research and institutional strategy, previously served as Director of Market Research at Unchained. Known for his Bitcoin maximalist perspective, Burnett views the cryptocurrency as a superior long-term store of value.

Eric Semler, Chairman of Semler Scientific, emphasized Burnett’s role in achieving the company’s vision, stating, “Joe’s expertise and conviction in Bitcoin’s potential will be instrumental in positioning Semler as one of the world’s most valuable companies”.

The announcement of Burnett’s appointment and the acquisition plan triggered an 11.95% surge in Semler’s stock price in after-hours trading, closing at $31.94 on June 19, 2025.

Market Impact and Industry Context

Challenges remain. Despite its Bitcoin gains, Semler’s core medical diagnostics business continues to report operational losses, and its stock has declined nearly 40% in 2025.

Bitcoin’s price volatility also poses risks, though optimistic forecasts, such as Pantera Capital’s prediction of $750,000 per Bitcoin by April 2028, suggest significant upside potential. Semler’s bold pivot underscores a growing corporate belief in Bitcoin’s transformative potential, setting the stage for a high-stakes financial journey.